1. Knockdown of chemokine receptor CXCR4 gene by RNA interference: Effects on the B16-F10 melanoma growth
   NAYARA DELGADO ANDRÉ et al, 2016, Oncology Reports CrossRef
2. Overexpression of amplified in breast cancer 1 (AIB1) gene promotes lung adenocarcinoma aggressiveness in vitro and in vivo by upregulating C‐X‐C motif chemokine receptor 4
   Liru He et al, 2018, Cancer Communications CrossRef
3. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy
   Ewelina Piktel et al, 2016, Journal of Nanobiotechnology CrossRef
4. The recent progresses in shRNA-nanoparticle conjugate as a therapeutic approach
   Rituparna Acharya, 2019, Materials Science and Engineering: C CrossRef
5. Nanocarriers in advanced drug targeting: setting novel paradigm in cancer therapeutics
   Md. Habban Akhter et al, 2018, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
6. Decoding the synergistic potential of MAZ‐51 and zingerone as therapy for melanoma treatment in alignment with sustainable development goals
   Kganya Letsoalo et al, 2024, Cell Biochemistry and Function CrossRef
7. NT5DC2 knockdown inhibits colorectal carcinoma progression by repressing metastasis, angiogenesis and tumor-associated macrophage recruitment: A mechanism involving VEGF signaling
   Zhenyu Zhu et al, 2020, Experimental Cell Research CrossRef
8. Chemokines as possible therapeutic targets in metastatic melanoma
   Charlise Basson et al, 2023, Cancer Medicine CrossRef
9. Chemokine Pathways in Cutaneous Melanoma: Their Modulation by Cancer and Exploitation by the Clinician
   Rebecca Adams et al, 2021, Cancers CrossRef
10. Spontaneous and Induced Animal Models for Cancer Research
    Anca Onaciu et al, 2020, Diagnostics CrossRef
11. Cancer Targeted Gene Therapy for Inhibition of Melanoma Lung Metastasis with eIF3i shRNA Loaded Liposomes
    Wen Xiao et al, 2020, Molecular Pharmaceutics CrossRef